Jeffrey S. Kahn, M.D., Ph.D. received his Bachelor of Science degree in Microbiology and Immunology from McGill University. He received his M.D. and a Ph.D. in Microbiology and Immunology from the State University of New York Health Science Center at Brooklyn. Dr. Kahn completed his internship, residency and chief residency in Pediatrics at Yale University and the Children’s Hospital at Yale-New Haven Hospital. Dr. Kahn stayed at Yale University to complete training in Pediatric Infectious Diseases. Thereafter, he joined the faculty at Yale University in the Department of Pediatrics in the Division of Infectious Diseases. He joined the faculty of UT Southwestern Medical Center in 2009.
Dr. Kahn’s research efforts have been focused human respiratory viruses, including respiratory syncytial virus (RSV) and new emerging human viruses. His laboratory was the first or among the first laboratories in the United States to describe the epidemiology and clinical manifestations of several newly identified viruses including human metapneumovirus, coronaviruses NL63 and HKU1, human bocavirus and polyomavirus WUV. His laboratory has described the molecular epidemiology of RSV and has characterized the glycoprotein sequences, completed phylogenetic analyses and defined the biological properties (e.g. induction of cytokines and chemokines) and induced gene expression profiles (using RNA-SEQ) of many of these RSV strains in primary human cells. Dr. Kahn’s current research efforts are focuses on mapping RSV phenotypes in the viral genome.
Dr. Kahn is the Director of the Pediatric Infectious Disease and the Pediatric Infectious Diseases Fellowship Program at UT Southwestern Medical Center and the Director of Infectious Diseases at Children’s Medical Center. Dr. Kahn is the Medical Director of Research at Children’s Medical Center.
- Medical School
- SUNY Health Science Center at Brooklyn College of Medicine (1991)
- Yale-New Haven Hospital (1994), Pediatrics
- Chief Resident
- Yale-New Haven Hospital (1995), Pediatrics
- Yale University School of Medicine (1998), Pediatric Infectious Diseases
- Cellular responses to RSV infection
- Emerging pathogens
- Recombinant negative stand RNA viruses
- Respiratory syncytial virus
- Identification of the point mutations in two vaccinia virus nucleoside triphosphate phosphohydrolase I temperature-sensitive mutants and role of this DNA-dependent ATPase enzyme in virus gene expression.
- Kahn JS, Esteban M Virology 1990 Feb 174 2 459-71
- The cis-acting DNA sequences required in vivo for bacteriophage Mu helper-mediated transposition and packaging.
- Harel J, Duplessis L, Kahn JS, DuBow MS Arch. Microbiol. 1990 154 1 67-72
- Molecular cloning, encoding sequence, and expression of vaccinia virus nucleic acid-dependent nucleoside triphosphatase gene.
- Rodriguez JF, Kahn JS, Esteban M Proc. Natl. Acad. Sci. U.S.A. 1986 Dec 83 24 9566-70
- Orientation and sequence analysis of right ends and target sites of bacteriophage mu and D108 insertions in the plasmid pSC101.
- Szatmari GB, Kahn JS, DuBow MS Gene 1986 41 2-3 315-9
Human Bocavirus: A Newly Discovered Human Parvovirus. In Scheld WM, Hooper DC, Hughes JM, eds. Emerging Infections 8.
Kahn JS, Tattersall P. (2008). Washington, DC:ASM Press; 21-38.
Honors & Awards
- Best Pediatric Specialists/Doctors in Dallas
D Magazine (2014-2018)
- Pediatric Chair’s Award, Yale University School of Medicine
- Mae Gailani Junior Faculty Award, Yale University School of Medicine
- Infectious Diseases Society of America (2010)
- American Society of Virology (2002)
- American Society of Microbiology (2001)
- Society of Pediatric Research (2001)
- American Academy of Pediatrics